-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M4vE0QF8XB00JmmLvDqWIngod7BbvzZVmE32tBDqLONZBDIGpb21HP9kDpR3EnZ1 4E1A+XdhnGrBQw4unEu69A== 0001104659-05-026924.txt : 20050611 0001104659-05-026924.hdr.sgml : 20050611 20050606153926 ACCESSION NUMBER: 0001104659-05-026924 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050531 ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20050606 DATE AS OF CHANGE: 20050606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MACROPORE INC CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-32501 FILM NUMBER: 05880519 BUSINESS ADDRESS: STREET 1: 6740 TOP GUN STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584580900 MAIL ADDRESS: STREET 1: 6740 TOP GUN STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 a05-10276_18k.htm 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 31, 2005

 

MACROPORE BIOSURGERY, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-32501

 

33-0827593

(State or Other Jurisdiction of
Incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer Identification
Number)

 

6740 Top Gun Street, San Diego, California 92121

(Address of principal executive offices, with zip code)

 

(858) 458-0900

(Registrant’s telephone number, including area code)

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 3.02                               Unregistered Sales of Equity Securities

 

On May 31, 2005, we sold 1,100,000 shares of common stock to a single purchaser for $11,000,000 cash.  There were no underwriting discounts or commissions, and the Section 4(2) exemption from the Securities Act’s registration requirement applied because there was only one purchaser.

 

At the same time, and as part of the same transaction, we issued to the purchaser a call option to buy, at any time through December 31, 2006, up to 2,200,000 additional shares of our common stock at $10.00 per share cash.  Again, there were no underwriting discounts or commissions in connection with the issuance of the call option (nor would there be any in connection with its exercise), and the Section 4(2) exemption from the Securities Act’s registration requirement applied.  The purchaser did not pay any additional consideration to acquire the call option.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MACROPORE BIOSURGERY, INC.

 

 

 

 

 

 

 

 

Date: June 1, 2005

By:

     /s/          CHRISTOPHER J. CALHOUN

 

 

Christopher J. Calhoun

 

 

Chief Executive Officer

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----